title: Intravenously delivered graphene nanosheets and multiwalled carbon nanotubes induce site-specific Th2 inflammatory responses via the IL-33/ST2 axis.
abstract: Carbon-based nanomaterials (CBN), such as graphene nanosheets (GNS) and multiwalled carbon nanotubes (MWCNT), have been proposed for potential nanomedicine applications such as biomedical devices and carriers for drug delivery. However, our current understanding regarding the systemic toxicity of these CBN through intravenous (iv) injection is limited. In this study, we compare the immune response resulting from GNS and MWCNT exposure. We hypothesize that iv administration of GNS and MWCNT would result in divergent systemic inflammatory responses due to physicochemical differences between these two CBN. In the lungs of C57BL/6 mice, GNS actuate a Th2 immune response 1 day following iv administration, which consists of neutrophilic influx and a significant increase in interleukin (IL)-5, IL-13, IL-33, and its soluble receptor (sST2) in the bronchoalveolar lavage fluid. MWCNT elicited a significant increase in the messenger ribonucleic acid expression of cytokines in the spleen including IL-4 and IL-33, which are associated with an increase in splenic cell differentiation (CD)4(+) and CD8(+) T-cells in C57BL/6 mice following iv injection. The observed Th2 responses in both the lung and spleen are absent in ST2(-/-) mice administrated GNS or MWCNT, suggesting a critical role for IL-33. In conclusion, the use of GNS or MWCNT as nanocarriers for drug delivery may result in Th2 immune responses that are mediated through the IL-33/ST2 axis and therefore may promote adverse allergic reactions.
authors: Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA.
authors: Xiaojia
authors: X
authors: Wang
authors: Ramakrishna
authors: R
authors: Podila
authors: Jonathan H
authors: JH
authors: Shannahan
authors: Apparao M
authors: AM
authors: Rao
authors: Jared M
authors: JM
authors: Brown
mesh_terms: D061605:Administration, Intravenous; D000704:Analysis of Variance; D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry / Q000166:cytology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D006108:Graphite / Q000633:toxicity*; D000072179:Interleukin-1 Receptor-Like 1 Protein; D000067596:Interleukin-33; D007378:Interleukins / Q000032:analysis* / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D049329:Nanostructures / Q000633:toxicity*; D037742:Nanotubes, Carbon / Q000633:toxicity*; D018123:Receptors, Interleukin / Q000032:analysis* / Q000235:genetics / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology / Q000378:metabolism*
chemical_list: C486189:Il1rl1 protein, mouse; C506535:Il33 protein, mouse; D000072179:Interleukin-1 Receptor-Like 1 Protein; D000067596:Interleukin-33; D007378:Interleukins; D037742:Nanotubes, Carbon; D018123:Receptors, Interleukin; D006108:Graphite
keywords: IL-33; ST2; Th2 immune responses; graphene nanosheets; multiwalled carbon nanotubes
references: Urol Oncol. 2008 Jan-Feb;26(1):74-85
references: 18190835
references: Allergol Int. 2010 Jun;59(2):143-60
references: 20414050
references: Nanotoxicology. 2013 Sep;7(6):1157-67
references: 22812632
references: J Immunol. 2001 Mar 1;166(5):3143-50
references: 11207266
references: Cytokine Growth Factor Rev. 2004 Apr-Jun;15(2-3):87-95
references: 15110792
references: Int J Nanomedicine. 2011;6:2963-79
references: 22162655
references: Chem Res Toxicol. 2011 Nov 21;24(11):2028-39
references: 21978239
references: Int J Nanomedicine. 2012;7:1345-56
references: 22419876
references: Nanotoxicology. 2013 Nov;7(7):1179-94
references: 22881873
references: Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):18882-6
references: 17135351
references: Small. 2008 Aug;4(8):1130-2
references: 18666166
references: Part Fibre Toxicol. 2011 Jul 22;8:21
references: 21781304
references: ACS Nano. 2010 Jun 22;4(6):3181-6
references: 20481456
references: Biomaterials. 2011 Jul;32(21):4867-76
references: 21459436
references: Biochim Biophys Acta. 2010 Aug;1806(1):29-35
references: 20193746
references: J Biol Chem. 2007 Sep 7;282(36):26369-80
references: 17623648
references: Drug Discov Today. 2010 Jun;15(11-12):428-35
references: 20451656
references: Int Immunol. 2010 Jun;22(6):479-89
references: 20501612
references: Eur J Immunol. 2011 Nov;41(11):3351-60
references: 21887788
references: Nanomedicine. 2011 Dec;7(6):983-91
references: 21616167
references: Toxicol Sci. 2009 May;109(1):113-23
references: 19293371
references: Drug Discov Today. 2010 Oct;15(19-20):842-50
references: 20727417
references: Part Part Syst Charact. 2013 Apr;30(4):365-373
references: 27642231
references: Toxicol Mech Methods. 2013 Mar;23(3):168-77
references: 23256453
references: Nat Med. 2009 Apr;15(4):410-6
references: 19330007
references: Nat Rev Immunol. 2010 Feb;10(2):103-10
references: 20081870
references: Acc Chem Res. 2013 Mar 19;46(3):750-60
references: 23035715
references: Curr Opin Immunol. 2010 Dec;22(6):800-6
references: 21071194
references: Nanotoxicology. 2013 Sep;7(6):1070-81
references: 22686327
references: Part Fibre Toxicol. 2012 Apr 03;9:8
references: 22472194
references: Semin Radiat Oncol. 2011 Apr;21(2):80-7
references: 21356476
references: J Autoimmun. 2010 May;34(3):J234-46
references: 19995678
references: Science. 2012 Feb 24;335(6071):984-9
references: 22323740
references: Nat Nanotechnol. 2010 Sep;5(9):683-9
references: 20693989
references: Part Fibre Toxicol. 2011 Aug 18;8:24
references: 21851604
references: Int J Nanomedicine. 2011;6:1945-54
references: 21976971
references: Nat Rev Immunol. 2002 May;2(5):309-22
references: 12033737
references: J Exp Med. 2012 Mar 12;209(3):607-22
references: 22329990
references: Part Fibre Toxicol. 2008 Nov 06;5:14
references: 18990217
references: Adv Drug Deliv Rev. 2011 Sep 16;63(12):1031-41
references: 21669239
references: J Exp Med. 2012 Jul 30;209(8):1505-17
references: 22802353
references: J Leukoc Biol. 2012 Jan;91(1):119-25
references: 22013230
references: Environ Toxicol. 2010 Dec;25(6):608-21
references: 20549644
references: J Toxicol Sci. 2012 Feb;37(1):177-89
references: 22293422
references: Adv Drug Deliv Rev. 2012 Dec;64(15):1700-5
references: 22634159
references: Nat Nanotechnol. 2009 Jul;4(7):451-6
references: 19581899
references: Immunity. 2005 Nov;23(5):479-90
references: 16286016
references: Small. 2012 Sep 24;8(18):2904-12
references: 22777948
references: Nanomedicine. 2010 Apr;6(2):277-88
references: 19699323
references: Toxicol Appl Pharmacol. 2009 Jun 15;237(3):306-16
references: 19371758